The growing number of prevalent arteriovenous (AV) accesses has been associated with an increase in the incidence of procedures being performed to maintain patency. To reduce the rate of unnecessary procedures, the 2019 Kidney Disease Outcome Quality Initiative guidelines addended the AV access surveillance recommendations, which includes clinical monitoring and assessment of dialysis adequacy alone. Abnormal clinical findings would necessitate follow-up angiography with or without confirmatory duplex ultrasound. Due to poor patency, increased surveillance schedules have been proposed to identify stenosis early and potentially prevent acute thrombotic events and AV access failure. In this review, we outlined current AV access monitoring and maintenance procedure recommendations, as described by the Centers for Medicare and Medicaid Services and 2019 Kidney Disease Outcome Quality Initiative guidelines. In addition, we highlight the findings of recently published randomized controlled trials that have examined increased surveillance schedules.
Keyphrases
- clinical practice
- quality improvement
- public health
- healthcare
- primary care
- randomized controlled trial
- chronic kidney disease
- end stage renal disease
- computed tomography
- optical coherence tomography
- liver failure
- affordable care act
- peritoneal dialysis
- clinical trial
- mental health
- systematic review
- drug induced
- hepatitis b virus
- mechanical ventilation